MALAT1 and neoplasm: As we discussed before, MALAT1 not only acted as a potential cancer biomarker [54] but also regulated angiogenesis in diabetic retinopathy [71], tumor [63, 72–74], hindlimb ischemia [75], and brain vascular endothelium [76].